Medical Access in Qatar

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Possession, importation, cultivation or distribution without explicit authorisation can trigger criminal penalties under Law No. 9 of 1987 and related implementing regulations. [1]Law No. 9 of 1987 [2]Qatar: Traveling with Medications Guidance.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. MDMA and related empathogens fall under the prohibitions and enforcement provisions of Qatar’s narcotics/psychotropic law; importation or possession without prior Ministry approval risks imprisonment and substantial fines. [1]Law No. 9 of 1987 [2]MoI drug awareness / enforcement guidance.

Esketamine (Spravato®) does not appear on public registries or official Ministry of Public Health communications as an authorised, routinely supplied/reimbursed antidepressant therapy in Qatar; there is no evidence of national reimbursement or routine clinical availability for insurance-covered psychiatric indications. If a clinician or hospital sought to provide it, the pathway would require regulatory import/registration approvals and government-level pharmaceutical import authorisation from the Ministry/Department of Pharmacology & Drug Control, and reimbursement would depend on private insurer policy or hospital self-funding (no public, national reimbursement entitlement is documented). The Ministry’s controls on psychotropic and narcotic imports mean novel or tightly‑controlled medicines typically require case-by-case approvals. [1]Qatar: Traveling with Medications Guidance [2]Law No. 9 of 1987. (No public record located of a formal Spravato registration with Qatar MoPH as of consultation of national legislative and public guidance.).

Ketamine is accepted and used within Qatar’s health system for legitimate medical indications such as anaesthesia, analgesia and emergency medicine under regulatory control; its clinical use is governed by hospital pharmacy regulations and the Ministry of Public Health’s pharmacology/drug control procedures. Ketamine is internationally recognised on the WHO Essential Medicines List for anaesthesia and analgesia, and Qatar’s regulatory framework treats ketamine as a controlled medicine that may be prescribed and supplied through authorised hospitals and pharmacies subject to documentation and dispensing controls. [1]WHO Model List of Essential Medicines (ketamine) [2]Qatar: Traveling with Medications Guidance.

Coverage / reimbursement nuance: public-sector provision of ketamine for inpatient anaesthesia and emergency care is provided through government hospitals as part of standard medically necessary services and is therefore covered under the hospital’s public financing model for the service (i.e., inpatient anaesthesia/ED care). However, outpatient/novel uses of ketamine for psychiatric indications (e.g., repeated off‑label ketamine infusions for depression) are not described in publicly-available national reimbursement schedules; such uses would typically be arranged through private providers or hospital-funded programmes and would be subject to hospital pharmacy approval and possibly special importation or controlled-substance handling requirements. Qatar’s procedures require that narcotic/psychotropic drugs be carried or imported only with Ministry approval and that prescribers and dispensers keep strict records. [3]MoI drug enforcement guidance [2]Qatar: Traveling with Medications Guidance.

Regional/state nuance: Qatar is a unitary state; regulatory decisions and import/dispensing controls are managed at the national level by the Ministry of Public Health (and its Department of Pharmacology & Drug Control). Local hospitals implement those national controls via their pharmacy and therapeutics committees and the General Directorate of Drug Enforcement for criminal enforcement. [4]Law No. 9 of 1987.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. DMT and its preparations are treated as psychotropic/narcotic substances under Law No. 9 of 1987; importation or possession without express Ministry approval carries criminal penalties. Note that ayahuasca preparations that contain DMT would be subject to the same national prohibitions unless an exceptional research/special permit were issued. [1]Law No. 9 of 1987 [2]Qatar: Traveling with Medications Guidance.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. 5‑MeO‑DMT possession, importation or distribution without prior authorisation would be prosecuted under the national narcotics/psychotropic legal framework. [1]Law No. 9 of 1987.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Ibogaine is not recognised in Qatar as an authorised therapeutic agent and would fall under the general prohibitions and enforcement mechanisms of Law No. 9 of 1987. [1]Law No. 9 of 1987.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Preparations containing DMT (such as ayahuasca) are subject to prohibition and importation/possession without specific Ministry permission is illegal. [1]Law No. 9 of 1987 [2]Qatar: Traveling with Medications Guidance.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. Mescaline and mescaline-containing cacti (if intended for consumption/extraction) are controlled; cultivation/possession/importation for illicit consumption is prosecutable under Law No. 9 of 1987. [1]Law No. 9 of 1987.

Currently classified as a strictly controlled substance under national drug scheduling laws, with no authorized medical use outside of approved clinical research. The 2C family (substituted phenethylamines) falls under psychotropic substance controls and illicit manufacture/possession/trafficking is subject to criminal sanctions. [1]Law No. 9 of 1987.